In Re: National Prescription Opiate Litigation

Track this case

Case overview

Case Number:

1:17-md-02804

See also:

Court:

Ohio Northern

Nature of Suit:

P.I.: Other

Multi Party Litigation:

Class Action, Multi-district Litigation

Judge:

Dan Aaron Polster (MDL 28

Firms

Companies

Government Agencies

Sectors & Industries:

  1. December 03, 2019

    Attys Report Broad Support For Opioid MDL Negotiation Class

    Attorneys representing cities and counties suing the drug industry over the opioid crisis told the Ohio federal judge overseeing litigation late Monday that a novel negotiation class proposal aimed at striking a global deal has won strong support across the country.

  2. November 27, 2019

    Schools Poised To Open New Front In Opioid MDL

    Some of the nation's biggest school districts are suing major drug companies over student learning disabilities and other problems allegedly linked to the opioid crisis, portending a potentially enormous new front in the multidistrict opioid litigation.

  3. November 19, 2019

    Opioid MDL Judge Plots New Bellwether Trials Across US

    The Ohio federal judge guiding multidistrict opioid litigation on Tuesday singled out numerous cases as good candidates for future bellwether trials, pitting a potpourri of plaintiffs against an assortment of drug companies.

  4. November 07, 2019

    Sparks Fly In Opioid MDL As Judge, Attys Debate Next Trials

    The Ohio federal judge supervising multidistrict opioid litigation has warned attorneys for local governments and drug companies that he will unilaterally select future bellwether trials unless they quickly do so themselves, according to a meeting transcript obtained Thursday by Law360.

  5. November 05, 2019

    Opioid MDL Judge Draws Fresh Fire From Pharmacies

    The Ohio federal judge overseeing multidistrict opioid litigation appears to have decided key issues about the MDL's future without first accepting input from pharmacy defendants, according to their strongly worded court filing late Tuesday.

  6. October 31, 2019

    Opioid MDL Attys Poised To Debate Next Bellwether Trials

    Attorneys in the opioid multidistrict litigation are gearing up for a closed-door debate next week over future bellwether trials, a showdown that will closely follow settlements that canceled the MDL's first trial.

  7. October 21, 2019

    $48B Opioid Deal Outcry May Presage Plaintiff Infighting

    A rapid outburst of opposition to a $48 billion "settlement framework" in opioid-crisis litigation unveiled Monday by four state attorneys general may signal a shift to local governments and states fighting not only with drug companies but also with each other.

  8. October 21, 2019

    State AGs Reach $48B Proposed Deal To End Opioid Cases

    Four attorneys general on Monday unveiled a proposed $48 billion deal with major drug companies — Teva Pharmaceuticals, Johnson & Johnson and the nation's largest drug distributors — to resolve a wave of opioid-crisis lawsuits.

  9. October 21, 2019

    Opioid Trial Halted By Drug Cos.' 11th Hour $260M Deal

    Two Ohio counties on Monday reached a deal worth $260 million with some of the nation's largest drug companies to avoid the first trial in opioid multidistrict litigation.

  10. October 17, 2019

    What To Watch As Opioid MDL Nears Moment Of Truth

    Amid whirlwind settlement talks, nationwide litigation over the pharmaceutical industry’s alleged role in the opioid crisis is on the cusp of a historic trial. Here, Law360 looks at settlement prospects and key issues if the epic courtroom showdown proceeds.